The European Brain Council (EBC) is very pleased to announce the start of the Rethinking Schizophrenia project, launched at the Brain Innovation Days, organised by EBC, which took place on 26-27 October 2023 in Brussels.
During the third edition of the event, participants had the opportunity to explore the Rethinking Schizophrenia poster exhibition, featuring portraits and quotes of people living with schizophrenia, patient advocates and caregivers. The exhibition fell under the #BeyondTheVoices campaign highlighting the need to rethink the way we deal with schizophrenia.
Beyond the Voices of Schizophrenia
Despite improvements and innovation in recent years, people living with schizophrenia face variations in access to optimal treatment and care. There is a lot about schizophrenia that is not fully understood and the high-quality care and support needed by people living with this condition is often unavailable.
There is a clear need to rethink the management of schizophrenia and redesign the care pathways to ensure optimal treatment and care for all people living with schizophrenia in Europe. Based around patient testimonies, the aim of the project is to highlight the need to optimise the way we manage schizophrenia by building a strong, coherent, evidence-based policy narrative which speaks to the current priorities in schizophrenia and draws from the current policy landscape in Europe. The first policy report Beyond the Voices of Schizophrenia is planned to be launched on the occasion of the Brain Awareness Week, taking place on 11-17 March 2024.
The Rethinking Schizophrenia project falls under the Rethinking the management of brain disorders series, research-driven projects offering policy recommendations to make tangible changes with the aim to improve the lives of people living with brain disorders, neurological and mental alike, across Europe.
The Rethinking Schizophrenia project is funded by Boehringer Ingelheim. All outputs are non-promotional and not specific to any particular treatment or therapy.